Furthermore, EZH2-mediated H3K27me3 on the promoters of CD274 (encoding PD-L1) and interferon regulatory factor 1 (IRF1) inhibits PD-L1 expression in HCC [15]. The gene discussed is EZH2; the disease is hepatocellular carcinoma.